What You Need For either format: Lyophilized peptide vial(s) separate retatrutide + cagrilintide, or one pre-mixed reta+cagri blend Bacteriostatic water (BAC water) sterile water with 0.9% benzyl alcohol preservative 30 mL syringe with 22-gauge needle for transferring BAC water 100-unit insulin syringes (U-100) for individual draws Alcohol swabs for vial-stopper sterilization Sharps container for used needles Clean flat surface with hands washed Pre-Mixed 12.5 / 2.5 mg Vial Reconstitution The 12.5/2.5 mg vial holds 15 mg total peptide (12.5 mg retatrutide + 2.5 mg cagrilintide) in a 5:1 mass ratio
IMPORTANT SAFETY INFORMATION: Common side effects (5% of users): nausea, vomiting, diarrhea, constipation, abdominal pain, decreased appetite, headache, fatigue, and injection-site reactionsreported with both Ozempic and Wegovy
Im in the lowest dose and I have had zero side effects
BPF intervention preserved SIRT1 activity and reduced the levels of the oxidative stress markers MDA and 8-hydroxy-2-deoxyguanosine (8-OHdG)
Medicinal-food homology substances possess both nutritional value and therapeutic efficacy, with good safety profiles suitable for long-term application
Since so many people think of a GLP-1 as the easy way out, I wanted to emphasize how hard Id been working, even using the word control to telegraph that I wasnt on the medication weight-loss bandwagon, because I didnt want people to think negatively of me
